Search alternatives:
point decrease » point increase (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 d » 100 μ (Expand Search), 100 _ (Expand Search), 100 g (Expand Search)
point decrease » point increase (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
100 d » 100 μ (Expand Search), 100 _ (Expand Search), 100 g (Expand Search)
-
1121
H<sub>2</sub>S decreases Na<sup>+</sup>/K<sup>+</sup>-ATPase currents of <i>Xenopus</i> lung epithelia.
Published 2014“…<b>B</b>) After permeabilisation with nystatin, NaHS (1 mM) was applied to the apical bath. I<sub>SC</sub> decreased significantly from 20.83±3.99 µA/cm<sup>2</sup> to 16.17±5.23 µA/cm<sup>2</sup> (n = 6, N = 6, p≤0.05). …”
-
1122
-
1123
Increased Dietary Intake of Saturated Fatty Acid Heptadecanoic Acid (C17:0) Associated with Decreasing Ferritin and Alleviated Metabolic Syndrome in Dolphins
Published 2015“…To assess potential protective factors against metabolic syndrome related to fish diets, fatty acids were compared between two dolphin populations with higher (n = 30, Group A) and lower (n = 19, Group B) mean insulin (11 ± 12 and 2 ± 5 μIU/ml, respectively; <i>P</i> < 0.0001) and their dietary fish. …”
-
1124
-
1125
-
1126
-
1127
-
1128
-
1129
-
1130
-
1131
Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo.
Published 2013“…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”
-
1132
-
1133
-
1134
-
1135
-
1136
-
1137
RA increases S100β+ and decreases peripherin+ cell prevalence while EDN3 decreases S100β+ cell prevalence.
Published 2013“…(A) The proportion of S100β+ cells was enriched by RA and decreased in response to EDN3 (B) RA increased, and EDN3 decreased the fraction of proliferating S100β+ cells. …”
-
1138
-
1139
GluN2A(D731N) reduces the agonist potency.
Published 2017“…<p>(<b>A,B</b>) Representative TEVC recordings obtained from oocytes expressing WT GluN1/GluN2A (WT 2A) receptors (<b>A</b>) and GluN1/GluN2A(D731N) (2A-D731N) receptors (<b>B</b>) in which the currents were evoked by increasing concentrations (μM) of glutamate (in the presence of 100 μM glycine) at the holding potential of -40 mV. …”
-
1140